These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Science watchers wink at the logic]. Taube A Lakartidningen; 1996 Apr; 93(16):1549-53; discussion 1553-5. PubMed ID: 8667757 [No Abstract] [Full Text] [Related]
27. [The ethics of medical statistics]. Kulcar Z; Hrabak-Zerjavić V Lijec Vjesn; 1983; 105(11-12):488-90. PubMed ID: 6664207 [No Abstract] [Full Text] [Related]
28. An introduction to statistical methods for health technology assessment. White SJ; Ashby D; Brown PJ Health Technol Assess; 2000; 4(8):i-iv, 1-59. PubMed ID: 10944742 [No Abstract] [Full Text] [Related]
29. The training of statisticians for cooperative clinical trials: a working statistician's viewpoint. Gehan EA Biometrics; 1980 Dec; 36(4):699-706. PubMed ID: 7248438 [TBL] [Abstract][Full Text] [Related]
30. [n or more in clinical trials? Zelen's models for randomization]. Taube A Lakartidningen; 1994 Mar; 91(10):977-82. PubMed ID: 8139323 [No Abstract] [Full Text] [Related]
31. Type II error in clinical trials. Gordon RS Gastroenterology; 1980 Jul; 79(1):180. PubMed ID: 7380213 [No Abstract] [Full Text] [Related]
32. [Size of the sample for clinical trials. How many patients are required?]. Schødt T Ugeskr Laeger; 1986 Sep; 148(37):2333-5. PubMed ID: 3775918 [No Abstract] [Full Text] [Related]
33. Papers from the International Society for Clinical Biostatistics. Sixth international meeting. September 1985. Stat Med; 1986; 5(5):399-553. PubMed ID: 3538260 [No Abstract] [Full Text] [Related]
34. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology]. Cachin Y; Flamant R; Richard J; Sancho-Garnier H Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330 [No Abstract] [Full Text] [Related]
35. [Introduction to the problems of clinical pharmacological research]. Rahlfs VW Int J Clin Pharmacol; 1972 Nov; 6(4):385-90. PubMed ID: 4565837 [No Abstract] [Full Text] [Related]
36. Group sequential and adaptive designs - a review of basic concepts and points of discussion. Vandemeulebroecke M Biom J; 2008 Aug; 50(4):541-57. PubMed ID: 18663761 [TBL] [Abstract][Full Text] [Related]
38. [What does a 50 percent reduction of risk mean? Results from clinical trials are often misleading]. Enkvist C; Werkö L Lakartidningen; 1994 Mar; 91(11):1091-2. PubMed ID: 8139338 [No Abstract] [Full Text] [Related]
39. [Principles of medical statistics. XII. Causal of pragmatic clinical research?]. Andersen B Nord Med; 1971 Dec; 86(48):1434-6. PubMed ID: 4943945 [No Abstract] [Full Text] [Related]
40. Statistical issues in the design and evaluation of clinical trials in Kawasaki disease. Gould AL Prog Clin Biol Res; 1987; 250():459-70. PubMed ID: 3423055 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]